Neoplasm Cases associated with Omalizumab, n Total cases, n ROR 95% CI
Breast cancer 232 34449 4.12 3.61 – 4.69
Male 2 285 5.94 1.48 – 23.9
Female 204 31917 3.41 2.97 – 3.92
Lung cancer 85 17012 3.04 2.45 – 3.76
Male 28 6858 3.46 2.38 – 5.01
Female 52 7568 3.66 2.78 – 4.80
Prostate cancer 57 13625 2.54 1.96 – 3.30
Colon cancer 46 7595 3.68 2.76 – 4.92
Male 18 3222 4.74 2.98 – 7.53
Female 25 3614 3.68 2.48 – 5.45
Malignant melanoma 45 8258 3.31 2.47 – 4.44
Male 14 3472 3.41 2.02 – 5.77
Female 26 3596 3.85 2.61 – 5.66
Thyroid cancer 22 3841 3.48 2.29 – 5.30
Male 2 771 2.19 0.55 – 8.77
Female 19 2364 4.28 2.72 – 6.72
Leukemia 21 4604 2.77 1.80 – 4.25
Male 9 1928 3.95 2.05 – 7.61
Female 9 2060 2.32 1.20 – 4.46
Neoplasms (total) 1380 515120 1.65 1.56 – 1.74
Male 415 186876 1.91 1.73 – 2.11
Female 868 253586 1.84 1.72 – 1.97